Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status
CONCLUSION: In this population-based study using the NCDB, immunotherapy treatment was associated with significantly improved OS compared to chemotherapy in patients with MSI-H metastatic colorectal cancer, but not in those with MSI-L/MSS metastatic colorectal cancer. Further studies are warranted to determine the optimal therapeutic approach for patients with MSI-L/MSS metastatic colorectal cancer.PMID:38689622 | PMC:PMC11056865 | DOI:10.5306/wjco.v15.i4.540
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Chen-Gu Niu Jing Zhang Aniket-Vijay Rao Utsav Joshi Patrick Okolo Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Databases & Libraries | Immunotherapy | Study